Analysis of FDA's Accelerated Approval Program Performance December 1992–December 2021

por Beakes-Read, Ginny, Neisser, Madison, Frey, Patrick, Guarducci, Mara
Publicado 2022

Medicinal Product Development and Regulatory Agilities Implemented During the Early Phases of the COVID-19 Pandemic: Experiences and Implications for the Future—An Industry View

por Geraci, Gaia, Bernat, Janis, Rodier, Céline, Acha, Virginia, Acquah, Jaqueline, Beakes-Read, Ginny
Publicado 2023

Walking the talk in digital transformation of regulatory review

por Khalil, Ramy, Macdonald, Judith C., Gustafson, Andrew, Aljuburi, Lina, Bisordi, Fabio, Beakes-Read, Ginny
Publicado 2023